by Jim Hoft, The Gateway Pundit:
The same technology that was used to treat COVID-19, which has seriously harmed millions of people and, in the worst cases, has caused death, will now be used to cure influenza.
The Phase 3 trial of an mRNA influenza vaccine has begun at two major pharmaceutical companies, Moderna and Pfizer.
TRUTH LIVES on at https://sgtreport.tv/
A major Phase 3 clinical trial assessing the efficacy, safety, tolerability, and immunogenicity of Pfizer’s quadrivalent modified RNA (modRNA) influenza vaccine candidate in about 25,000 healthy U.S. adults has begun dosing participants, the pharmaceutical giant reported last month.
“For years, there has been a need to better address the burden of influenza, despite the use of existing seasonal flu vaccines. Our experience with RNA viruses and mRNA technology has given us an even deeper understanding of the opportunity to potentially provide more efficacious vaccines that could further reduce the yearly rates of the severe outcomes of viral disease like flu, including hospitalization and death,” claimed Annaliesa Anderson, Ph.D., Senior Vice President and Chief Scientific Officer, Vaccine Research and Development, Pfizer.
“We are excited to start the first Phase 3 efficacy study of an mRNA-based influenza vaccine that could potentially deliver an improved flu vaccine to help address the significant burden of this disease,” she added.
Pfizer ensures that its clinical trial participants properly represent the racial and ethnic diversity of the countries in which they are conducted.
Read More @ TheGatewayPundit.com
